跳至主要内容
临床试验/CTRI/2024/11/076632
CTRI/2024/11/076632尚未招募4 期

A clinical study to evaluate the efficacy of Virechan karma with Haritakyadi Modak in the management of Vicharchika with special reference to Eczema

Soumya Suresh Chinta1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年11月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Effect of drug on morphological features of the lesion: Using butter paper external margins of eczematic patch will be marked before and after treatment. Using maximum longitudinal length and vertical length area will be calculated before and after.

研究概览

简要总结

Vicharchika (Eczema) is one of the Kshudra Kushthas (chronic skin disorder) and is included under Rakta Pradoshaja Vikaras (disorder due to blood vitiation). Being a type of Kushtha, recurrences and chronic course is common for this disease. Vicharchika can be correlated with eczema which is characterized by persistent or recurring skin rashes, running a chronic course, and has a tendency of exacerbations. Hence, while selecting regimen for its total eradication, in addition to its own treatment, it is necessary to take care of its recurrences also. The main line of treatment described for Kushtha is repeated Shodhana (bio-purification), so that the disease can be eradicated from the root. Of Panchakarma, Virechana (systemic purification by giving purgative drug) is better for the skin diseases where Pitta and Rakta are mainly involved.

In modern science, treatment of Eczema is giving oral medications like NSAIDS, corticosteroids and anti-histamines. Topically, corticosteroids are given to reduce itchiness, swelling and redness. In Ayurveda, the main line of treatment of Vicharchika vyadhi is repeated shodhan (bio-purification), since Virechan karma is advised for all skin diseases, I’ve taken Virechan with Haritakyadi modak in Vicharchika (Eczema) for my study.

The participant will be given rukshan drug as per necessity.  For internal Snehan, Go ghrut will be provided with instruction regarding dose according to the koshtha and status of agni of the participant after doing rukshan. External snehan and swedan will be done for 2 days.  Virechan drug will be given in the early morning and the number of vega and symptoms will be assessed for evaluating the type of shuddhi. Sansarjan Kram will be advised for 3, 5 or 7 days as per the type of shuddhi happened on the day of virechan.

The changes in the symptoms will be evaluated on daily basis and data would be analyzed on the basis of data collected by applying appropriate statistical tools.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients of any gender, between age 18-55 years of age, 2)Patiens having symptoms of vicharchika like kandu, strava, pidika, vaivarnya and rukshata.
  • Patients willing to participate in the study.

排除标准

  • Patients diagnosed with carcinoma, tuberculosis, HIV positive or any other life-threatening condition.
  • Patients having any ano-rectal diseases like fistula, fissure-in-ano, hemmorhoids.
  • Pregnant and lactating women.
  • Patient with other debilitating disease like TB/SLE 5)Patients not fit for Virechan karma.
  • (Virechan ayogya patients).

结局指标

主要结局

Effect of drug on morphological features of the lesion: Using butter paper external margins of eczematic patch will be marked before and after treatment. Using maximum longitudinal length and vertical length area will be calculated before and after.

时间窗: 15 days

次要结局

  • Effect of drug on vaivarnya (de-pigmentation) of the lesion.(Effect of drug on kandu (itching) of the lesion.)

研究者

发起方
Soumya Suresh Chinta
申办方类型
Other [[self]]
责任方
Principal Investigator
主要研究者

Soumya Suresh Chinta

APMs Ayurved mahavidyalaya Sion Mumbai

研究点 (1)

Loading locations...

相似试验